中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
24期
19-19,21
,共2页
冠心病%心力衰竭%曲美他嗪
冠心病%心力衰竭%麯美他嗪
관심병%심력쇠갈%곡미타진
Coronary heart disease%Heart failure%Trimetazidine
目的：探讨曲美他嗪治疗冠心病心力衰竭患者的临床疗效。方法：2012年1月-2014年1月收治冠心病心力衰竭患者60例，随机分为观察组和对照组各30例，对照组给予常规治疗，观察组在对照组的基础上加用曲美他嗪治疗，对两组疗效进行比较。结果：观察组治疗后的 LVEF 和6 min 步行距离检测情况均明显优于对照组，总有效率(90.0%)明显大于对照组(76.7%)，且P＜0.05；两组治疗期间均未见明显不良反应。结论：曲美他嗪在冠心病心力衰竭中的治疗效果显著，值得临床推广。
目的：探討麯美他嗪治療冠心病心力衰竭患者的臨床療效。方法：2012年1月-2014年1月收治冠心病心力衰竭患者60例，隨機分為觀察組和對照組各30例，對照組給予常規治療，觀察組在對照組的基礎上加用麯美他嗪治療，對兩組療效進行比較。結果：觀察組治療後的 LVEF 和6 min 步行距離檢測情況均明顯優于對照組，總有效率(90.0%)明顯大于對照組(76.7%)，且P＜0.05；兩組治療期間均未見明顯不良反應。結論：麯美他嗪在冠心病心力衰竭中的治療效果顯著，值得臨床推廣。
목적：탐토곡미타진치료관심병심력쇠갈환자적림상료효。방법：2012년1월-2014년1월수치관심병심력쇠갈환자60례，수궤분위관찰조화대조조각30례，대조조급여상규치료，관찰조재대조조적기출상가용곡미타진치료，대량조료효진행비교。결과：관찰조치료후적 LVEF 화6 min 보행거리검측정황균명현우우대조조，총유효솔(90.0%)명현대우대조조(76.7%)，차P＜0.05；량조치료기간균미견명현불량반응。결론：곡미타진재관심병심력쇠갈중적치료효과현저，치득림상추엄。
Objective:To explore the clinical effect of trimetazidine in the treatment of patients with coronary heart disease heart failure.Methods:60 cases with coronary heart disease heart failure were selected from January 2012 to January 2014.They were randomly divided into the observation group and the control group with 30 cases in each.The control group were given conventional treatment.The observation group were given trimetazidine treatment on the basis of the control group.The curative effects of two groups were compared.Results:After treatment,LVEF and 6 minutes walking distance detection situation of the observation group were obviously better than those of the control group.The total effective rate of the observation(90.0%) was obviously higher than that of control group(76.7%),and P<0.05.There were no obvious adverse reactions in two groups during the treatment.Conclusion:The trimetazidine in the treatment of coronary heart disease heart failure has significant effect.It is worthy of clinical promotion.
